Found: 8
Select item for more details and to access through your institution.
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting.
- Published in:
- Drug Safety, 2023, v. 46, n. 2, p. 157, doi. 10.1007/s40264-022-01263-3
- By:
- Publication type:
- Article
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting.
- Published in:
- Drug Safety, 2023, v. 46, n. 2, p. 175, doi. 10.1007/s40264-022-01262-4
- By:
- Publication type:
- Article
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes.
- Published in:
- Drug Safety, 2023, v. 46, n. 2, p. 209, doi. 10.1007/s40264-022-01261-5
- By:
- Publication type:
- Article
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study.
- Published in:
- Drug Safety, 2023, v. 46, n. 2, p. 195, doi. 10.1007/s40264-022-01260-6
- By:
- Publication type:
- Article
Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature.
- Published in:
- Drug Safety, 2023, v. 46, n. 2, p. 109, doi. 10.1007/s40264-022-01258-0
- By:
- Publication type:
- Article
The Food and Drug Administration's (FDA's) Drug Safety Surveillance During the COVID-19 Pandemic.
- Published in:
- Drug Safety, 2023, v. 46, n. 2, p. 145, doi. 10.1007/s40264-022-01256-2
- By:
- Publication type:
- Article
Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration.
- Published in:
- Drug Safety, 2023, v. 46, n. 2, p. 129, doi. 10.1007/s40264-022-01255-3
- By:
- Publication type:
- Article
Compliance with Prescribing and Dispensing Conditions for Valproate and Related Substances in Girls and Women of Childbearing Potential: A Survey of Community Pharmacists in France.
- Published in:
- Drug Safety, 2023, v. 46, n. 2, p. 121, doi. 10.1007/s40264-022-01234-8
- By:
- Publication type:
- Article